Rare UNC13B variations and risk of schizophrenia: Whole-exome sequencing in a multiplex family and follow-up resequencing and a case–control study

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 6, 2016, Pages 797-805

  Egawa, Jun ^a   Hoya, Satoshi ^a   Watanabe, Yuichiro ^a   Nunokawa, Ayako ^a,b   Shibuya, Masako ^a   Ikeda, Masashi ^c   Inoue, Emiko ^a   Okuda, Shujiro ^a   Kondo, Kenji ^c   Saito, Takeo ^c   Kaneko, Naoshi ^a,b   Muratake, Tatsuyuki ^a,d   Igeta, Hirofumi ^a   Iwata, Nakao ^c   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Oojima Hospital   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Furumachi Mental Clinic   (Japan)

Author keywords

gene based analysis; Japanese; meta analysis; missense variation

Indexed keywords

DNA; NERVE PROTEIN; UNC13B PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXOME; EXON; FAMILY; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNC13B GENE; CASE REPORT; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; METABOLISM; PEDIGREE; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; EXOME; EXONS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; PEDIGREE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84961266979     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32444     Document Type: Article

References (38)

1. Augustin I, Betz A, Herrmann C, Jo T, Brose N. 1999a. Differential expression of two novel Munc13 proteins in rat brain. Biochem J 337:363–371.
2. Augustin I, Rosenmund C, Südhof TC, Brose N. 1999b. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 400:457–461.
3. Bi C, Wu J, Jiang T, Liu Q, Cai W, Yu P, Cai T, Zhao M, Jiang YH, Sun ZS. 2012. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat 33:1635–1638.
4. Breustedt J, Gundlfinger A, Varoqueaux F, Reim K, Brose N, Schmitz D. 2010. Munc13-2 differentially affects hippocampal synaptic transmission and plasticity. Cereb Cortex 20:1109–1120.
5. Cirulli ET, Goldstein DB. 2010. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11:415–425.
6. Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, Hsu S, Choi J, Ryten M; UK Brain Expression Consortium, Hardy J, Ryten M, Trabzuni D, Weale ME, Ramasamy A, Smith C, Sassi C, Bras J, Gibbs JR, Hernandez DG, Lupton MK, Powell J, Forabosco P, Ridge PG, Corcoran CD, Tschanz JT, Norton MC, Munger RG, Schmutz C, Leary M, Demirci FY, Bamne MN, Wang X, Lopez OL, Ganguli M, Medway C, Turton J, Lord J, Braae A, Barber I, Brown K, Alzheimer's Research Consortium UK, Passmore P, Craig D, Johnston J, McGuinness B, Todd S, Heun R, Kölsch H, Kehoe PG, Hooper NM, Vardy ER, Mann DM, Pickering-Brown S, Brown K, Kalsheker N, Lowe J, Morgan K, David Smith A, Wilcock G, Warden D, Holmes C, Pastor P, Lorenzo-Betancor O, Brkanac Z, Scott E, Topol E, Morgan K, Rogaeva E, Singleton AB, Hardy J, Kamboh MI, St George-Hyslop P, Cairns N, Morris JC, Kauwe JS, Goate AM. 2014. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 505:550–554.
7. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimäki T, Lin CF, Ma'ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnström K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-Rüther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RK; DDD Study; Homozygosity Mapping Collaborative for Autism; UK10 K Consortium, Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD. 2014. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515:209–215.
8. Egawa J, Watanabe Y, Sugimoto A, Nunokawa A, Shibuya M, Igeta H, Inoue E, Hoya S, Orime N, Hayashi T, Sugiyama T, Someya T. 2015a. Whole-exome sequencing in a family with a monozygotic twin pair concordant for autism spectrum disorder and a follow-up study. Psychiatry Res 229:599–601.
9. Egawa J, Watanabe Y, Wang C, Inoue E, Sugimoto A, Sugiyama T, Igeta H, Nunokawa A, Shibuya M, Kushima I, Orime N, Hayashi T, Okada T, Uno Y, Ozaki N, Someya T. 2015b. Novel rare missense variations and risk of autism spectrum disorder: Whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population. PLoS ONE 10:e0119413.
10. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan MC. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179–184.
11. Gonzalez-Mantilla AJ, Moreno-De-Luca A, Ledbetter DH, Martin CL. 2016. A cross-disorder method to identify novel candidate genes for developmental brain disorders. JAMA Psychiatry 73:275–283.
12. Hall J, Trent S, Thomas KL, O'Donovan MC, Owen MJ. 2015. Genetic risk for schizophrenia: Convergence on synaptic pathways involved in plasticity. Biol Psychiatry 77:52–58.
13. Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I, Ito Y, Nakamura Y, Kishi T, Okumura T, Fukuo Y, Williams HJ, Hamshere ML, Ivanov D, Inada T, Suzuki M, Hashimoto R, Ujike H, Takeda M, Craddock N, Kaibuchi K, Owen MJ, Ozaki N, O'Donovan MC, Iwata N. 2011. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 69:472–448.
14. Ikeda M, Aleksic B, Yamada K, Iwayama-Shigeno Y, Matsuo K, Numata S, Watanabe Y, Ohnuma T, Kaneko T, Fukuo Y, Okochi T, Toyota T, Hattori E, Shimodera S, Itakura M, Nunokawa A, Shibata N, Tanaka H, Yoneda H, Arai H, Someya T, Ohmori T, Yoshikawa T, Ozaki N, Iwata N. 2013. Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population. Mol Psychiatry 18:636–638.
15. Inoue E, Watanabe Y, Egawa J, Sugimoto A, Nunokawa A, Shibuya M, Igeta H, Someya T. 2015. Rare truncating variations and risk of autism spectrum disorder: Whole-exome sequencing of a multiplex family and follow-up study in a Japanese population. Psychiatry Clin Neurosci 69:472–476.
16. Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei L, Willsey AJ, Yamrom B, Lee YH, Grabowska E, Dalkic E, Wang Z, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma B, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515:216–221.
17. Jahn R, Fasshauer D. 2012. Molecular machines governing exocytosis of synaptic vesicles. Nature 490:201–207.
18. James DJ, Martin TF. 2013. CAPS and Munc13: CATCHRs that SNARE vesicles. Front Endocrinol (Lausanne) 4:187.
19. Kaneko N, Muratake T, Kuwabara H, Kurosaki T, Takei M, Ohtsuki T, Arinami T, Tsuji S, Someya T. 2007. Autosomal linkage analysis of a Japanese single multiplex schizophrenia pedigree reveals two candidate loci on chromosomes 4q and 3q. Am J Med Genet B Neuropsychiatr Genet 144B:735–742.
20. Kavanagh DH, Tansey KE, O'Donovan MC, Owen MJ. 2015. Schizophrenia genetics: Emerging themes for a complex disorder. Mol Psychiatry 20:72–76.
21. Lee S, Teslovich TM, Boehnke M, Lin X. 2013. General framework for meta-analysis of rare variants in sequencing association studies. Am J Hum Genet 93:42–53.
22. Li J, Cai T, Jiang Y, Chen H, He X, Chen C, Li X, Shao Q, Ran X, Li Z, Xia K, Liu C, Sun ZS, Wu J. 2016. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry 21:290–207.
23. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373:234–239.
24. Nunokawa A, Watanabe Y, Kaneko N, Sugai T, Yazaki S, Arinami T, Ujike H, Inada T, Iwata N, Kunugi H, Sasaki T, Itokawa M, Ozaki N, Hashimoto R, Someya T. 2010. The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case-control studies and an updated meta-analysis. Schizophr Res 116:61–67.
25. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kähler A, Duncan L, Stahl E, Genovese G, Fernández E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PK, Banks E, Shakir K, Garimella K, Fennell T, DePristo M, Grant SG, Haggarty SJ, Gabriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P. 2014. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185–190.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.
27. Rosenmund C, Sigler A, Augustin I, Reim K, Brose N, Rhee JS. 2002. Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. Neuron 33:411–424.
28. Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, Murtha MT, Bal VH, Bishop SL, Dong S, Goldberg AP, Jinlu C, Keaney JF 3rd, Klei L, Mandell JD, Moreno-De-Luca D, Poultney CS, Robinson EB, Smith L, Solli-Nowlan T, Su MY, Teran NA, Walker MF, Werling DM, Beaudet AL, Cantor RM, Fombonne E, Geschwind DH, Grice DE, Lord C, Lowe JK, Mane SM, Martin DM, Morrow EM, Talkowski ME, Sutcliffe JS, Walsh CA, Yu TW; Autism Sequencing Consortium, Ledbetter DH, Martin CL, Cook EH, Buxbaum JD, Daly MJ, Devlin B, Roeder K, State MW. 2015. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87:1215–1233.
29. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427.
30. Südhof TC. 2012. The presynaptic active zone. Neuron 75:11–25.
31. Timms AE, Dorschner MO, Wechsler J, Choi KY, Kirkwood R, Girirajan S, Baker C, Eichler EE, Korvatska O, Roche KW, Horwitz MS, Tsuang DW. 2013. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry 70:582–590.
32. Turner TN, Hormozdiari F, Duyzend MH, McClymont SA, Hook PW, Iossifov I, Raja A, Baker C, Hoekzema K, Stessman HA, Zody MC, Nelson BJ, Huddleston J, Sandstrom R, Smith JD, Hanna D, Swanson JM, Faustman EM, Bamshad MJ, Stamatoyannopoulos J, Nickerson DA, McCallion AS, Darnell R, Eichler EE. 2016. Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA. Am J Hum Genet 98:58–74.
33. van Os J, Kapur S. 2009. Schizophrenia. Lancet 374:635–645.
34. Varoqueaux F, Sigler A, Rhee JS, Brose N, Enk C, Reim K, Rosenmund C. 2002. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc Natl Acad Sci USA 99:9037–9042.
35. Watanabe Y, Muratake T, Kaneko N, Fukui N, Nara Y, Someya T. 2007. No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population. Psychiatry Res 153:1–6.
36. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. 2006. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res 84:29–35.
37. Watanabe Y, Nunokawa A, Shibuya M, Ikeda M, Hishimoto A, Kondo K, Egawa J, Kaneko N, Muratake T, Saito T, Okazaki S, Shimasaki A, Igeta H, Inoue E, Hoya S, Sugai T, Sora I, Iwata N, Someya T. 2016. Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population. Psychiatry Res 235:13–18.
38. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare variant association testing for sequencing data using the sequence Kernel association test (SKAT). Am J Hum Genet 89:82–93.